Outcomes Data of Adipose Stem Cells to Treat Osteoarthritis

StemGenex

Status: Unknown

Conditions: Osteoarthritis

Study type: Observational

Funder types: Industry

Identifiers

NCT02241408

SVF01OA

ASCOA-01

Details and patient eligibility

About

The purpose of this study is to determine the impact that treatment with a cellular concentrate derived from an individual's own fat, known as the stromal vascular fraction (SVF), has on joint pain and functionality in people with Osteoarthritis (OA). SVF contains components with "regenerative" properties, including stem cells that have shown promise for ameliorating specific disease conditions. This study is designed to evaluate joint pain and functionality changes in individuals with OA for up to 12 months following SVF treatment.

Enrollment: 100 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Fluent in English
• Over the age of 18
• Diagnosed with OA of the knee and/or hip
• Scheduled for intravenous and intra-articular administrations of autologous SVF
• Capable of understanding and willing to sign informed consent
• Willing and able to complete brief phone interviews
• Willing and able to complete online surveys

Exclusion criteria

• Co-morbidity with an autoimmune disorder
• Pregnant, may become pregnant, or breastfeeding
• Subjects for which baseline data is not available